#EndDIPG

Kelsey Nemec - Run of Hope Seattle Recent federal cuts to the NIH and the projected cuts to Medicaid will devastate health care and scientific advancements for all Americans. We will likely lose a generation of young scientists given t...

Given the recent and devastating cuts to the NIH, my colleagues and I from @seattlechildrens.org are running a 5k on 9/21 to raise money for pediatric cancer research. Please consider donating, joining our team, or simply sharing this post to help raise awareness! #EndDIPG

runsignup.com/nemec

If you told me when I was at @aucmed.bsky.social that I'd apply for an R01 - much less that it would score so well that it would converted to an R37 MERIT award - I dont know what I'd have said. This ones for the Caribbean grads! And thanks to @seattlechildrens.bsky.social and the #NIH! #EndDIPG

Seattle Children's on LinkedIn: CAR T Cell Therapy Offers Hope Against DIPG Gavin wasn’t expected to live to age 3, but today he’s a thriving kindergartener! Gavin was diagnosed with diffuse intrinsic pontine glioma (#DIPG), an…

So great to see that hard work can make a difference!
And incredibly honoured to become a part of this lab.
#ENDDIPG

www.linkedin.com/posts/seattl...

Intracerebroventricular B7-H3 CAR T cells for children and young adults with diffuse intrinsic pontine glioma Diffuse intrinsic pontine glioma (DIPG) is a fatal central nervous system (CNS) tumor with a median survival of 11 months. Chimeric antigen receptor (CAR) T cells are clinically effective against hema...

In revision but sharing the preprint of Seattle Children's completed first-in-human phase 1 #clinicaltrial of intracranial #B7-H3 #CARTcells for children with #DIPG. We hope this work solidifies the foundation of this #immunotherapy for children w/ #braintumors. #EndDIPG
doi.org/10.21203/rs....